Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Brian Gardner, Stifel chief Washington policy strategist, joins 'Closing Bell Overtime' to talk how to play the Trump trade ...

Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...

Stifel initiated coverage on Cytokinetics Incorporated (NASDAQ:CYTK), noting the company’s catalyst rich one to two years.

Stifel initiated coverage of Edgewise Therapeutics (EWTX) with a Hold rating and $30 price target The firm says that while Edgewise has “very ...

Stifel initiated coverage of Cytokinetics (CYTK) with a Buy rating and $80 price target Cytokinetics “is an out-of-favor stock” following the ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Cramer recommended buying ASML Holding N.V. ASML, adding that it is a “remarkably great” company. Supporting his view, Wells ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

Kalispell Mayor Mark Johnson will not seek reelection. “I didn’t want to run again this last time, this time for sure, ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...